These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Innate immune tissue injury and murine HGA: tissue injury in the murine model of granulocytic anaplasmosis relates to host innate immune response and not pathogen load. Scorpio DG; Von Loewenich FD; Bogdan C; Dumler JS Ann N Y Acad Sci; 2005 Dec; 1063():425-8. PubMed ID: 16481553 [TBL] [Abstract][Full Text] [Related]
4. Modulation of leukocyte populations and immune responses in sheep experimentally infected with Anaplasma (formerly Ehrlichia) phagocytophilum. Whist SK; Storset AK; Johansen GM; Larsen HJ Vet Immunol Immunopathol; 2003 Aug; 94(3-4):163-75. PubMed ID: 12909412 [TBL] [Abstract][Full Text] [Related]
6. Impairment of gamma interferon signaling in human neutrophils infected with Anaplasma phagocytophilum. Bussmeyer U; Sarkar A; Broszat K; Lüdemann T; Möller S; van Zandbergen G; Bogdan C; Behnen M; Dumler JS; von Loewenich FD; Solbach W; Laskay T Infect Immun; 2010 Jan; 78(1):358-63. PubMed ID: 19858302 [TBL] [Abstract][Full Text] [Related]
7. Interferon-γ-dependent control of Anaplasma phagocytophilum by murine neutrophil granulocytes. Gussmann K; Kirschnek S; von Loewenich FD Parasit Vectors; 2017 Jul; 10(1):329. PubMed ID: 28697801 [TBL] [Abstract][Full Text] [Related]
8. CXCR2 blockade influences Anaplasma phagocytophilum propagation but not histopathology in the mouse model of human granulocytic anaplasmosis. Scorpio DG; Akkoyunlu M; Fikrig E; Dumler JS Clin Diagn Lab Immunol; 2004 Sep; 11(5):963-8. PubMed ID: 15358660 [TBL] [Abstract][Full Text] [Related]
9. Functional inhibition or genetic deletion of acid sphingomyelinase bacteriostatically inhibits Anaplasma phagocytophilum infection in vivo. Naimi WA; Gumpf JJ; Cockburn CL; Camus S; Chalfant CE; Li PL; Carlyon JA Pathog Dis; 2021 Jan; 79(1):. PubMed ID: 33220685 [TBL] [Abstract][Full Text] [Related]
10. IL-12/23p40-dependent clearance of Anaplasma phagocytophilum in the murine model of human anaplasmosis. Pedra JH; Tao J; Sutterwala FS; Sukumaran B; Berliner N; Bockenstedt LK; Flavell RA; Yin Z; Fikrig E FEMS Immunol Med Microbiol; 2007 Aug; 50(3):401-10. PubMed ID: 17521390 [TBL] [Abstract][Full Text] [Related]
11. Comparative strain analysis of Anaplasma phagocytophilum infection and clinical outcomes in a canine model of granulocytic anaplasmosis. Scorpio DG; Dumler JS; Barat NC; Cook JA; Barat CE; Stillman BA; DeBisceglie KC; Beall MJ; Chandrashekar R Vector Borne Zoonotic Dis; 2011 Mar; 11(3):223-9. PubMed ID: 20846015 [TBL] [Abstract][Full Text] [Related]
12. VirB10 vaccination for protection against Anaplasma phagocytophilum. Crosby FL; Lundgren AM; Hoffman C; Pascual DW; Barbet AF BMC Microbiol; 2018 Dec; 18(1):217. PubMed ID: 30563470 [TBL] [Abstract][Full Text] [Related]
19. Vaccinomics Approach to the Identification of Candidate Protective Antigens for the Control of Tick Vector Infestations and Contreras M; Alberdi P; Fernández De Mera IG; Krull C; Nijhof A; Villar M; De La Fuente J Front Cell Infect Microbiol; 2017; 7():360. PubMed ID: 28848718 [No Abstract] [Full Text] [Related]